Lung Diseases, Interstitial
Conditions
Brief summary
The purpose of this study is to investigate new therapies for advanced lung disease.
Detailed description
This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.
Interventions
OTHERnovel biomarkers of lung disease
we will be identifying molecular, genetic, and cellular markers of lung disease
Sponsors
Ohio State University
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* any one on lung transplant list
Exclusion criteria
* HIV positive
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The development of novel therapeutics for interstial lung disease | 10 years | Our research on these human lung cells will provide critical data which will aid in the diagnosis and treatment of a variety of different lung diseases, which have no cure. |
Countries
United States
Outcome results
None listed